Loading...
Header Logo
Keywords
Last Name
Institution

Andrew Renshaw

TitleAssistant Professor
InstitutionUniversity of Houston
DepartmentPhysics
Address4800 Calhoun Rd
Houston TX 77004
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Renshaw AA, Gould EW. Impact of Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Features on Adequacy Criteria and Risk of Malignancy of Thyroid Fine-Needle Aspiration. Am J Clin Pathol. 2017 Sep 01; 148(3):259-263. PMID: 28821191.
      View in: PubMed
    2. Renshaw AA, Gould EW. Incidence and significance of true papillae in thyroid fine needle aspiration. Diagn Cytopathol. 2017 Aug; 45(8):689-692. PMID: 28480631.
      View in: PubMed
    3. Vivero M, Renshaw AA, Krane JF. Adequacy criteria for thyroid FNA evaluated by ThinPrep slides only. Cancer. 2017 Jul; 125(7):534-543. PMID: 28388017.
      View in: PubMed
    4. Renshaw MA, Renshaw SA, Mena-Allauca M, Carrion PP, Mei X, Narciandi A, Gould EW, Renshaw AA. Performance of a Web-based Method for Generating Synoptic Reports. J Pathol Inform. 2017; 8:13. PMID: 28382227.
      View in: PubMed
    5. Patel SA, Chen MH, Loffredo M, Renshaw A, Kantoff PW, D'Amico AV. The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer. Prostate Cancer Prostatic Dis. 2017 Jun; 20(2):234-240. PMID: 28117382.
      View in: PubMed
    6. Renshaw AA, Gould EW. Comparison of Accuracy and Speed of Information Identification by Nonpathologists in Synoptic Reports With Different Formats. Arch Pathol Lab Med. 2017 Mar; 141(3):418-422. PMID: 28055242.
      View in: PubMed
    7. Renshaw AA, Gould EW. The Cost of Synoptic Reporting. Arch Pathol Lab Med. 2017 Jan; 141(1):15-16. PMID: 28029905.
      View in: PubMed
    8. Renshaw AA, Mena-Allauca M, Gould EW. Reporting Gleason grade/score in synoptic reports of radical prostatectomies. J Pathol Inform. 2016; 7:54. PMID: 28163976.
      View in: PubMed
    9. Sanford NN, Chen MH, Loffredo M, Renshaw A, Kantoff PW, D'Amico AV. Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death. Prostate Cancer Prostatic Dis. 2017 Mar; 20(1):79-84. PMID: 27824043.
      View in: PubMed
    10. Renshaw A, Goodwin PC. Injury incidence in a Premier League youth soccer academy using the consensus statement: a prospective cohort study. BMJ Open Sport Exerc Med. 2016; 2(1):e000132. PMID: 27900186.
      View in: PubMed
    11. Giacalone NJ, Wu J, Chen MH, Renshaw A, Loffredo M, Kantoff PW, D'Amico AV. Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial. J Clin Oncol. 2016 Sep 06. PMID: 27601545.
      View in: PubMed
    12. Renshaw AA, Gould EW. Impact of specific patterns on the sensitivity for follicular and Hurthle cell carcinoma in thyroid fine-needle aspiration. Cancer. 2016 Oct; 124(10):729-736. PMID: 27322887.
      View in: PubMed
    13. Renshaw AA, Underwood D, Aramoni G, Cash B, Croyle M, Deeds D, Dolar S, Gmitro S, Ray N, Sabo D, Shorie JA, Springer B, Weber Moffsinger D, Elsheikh TM. Time consumed by microscopic and nonmicroscopic tasks in image-assisted gynecologic screening: Implications for workload assessment. Cancer Cytopathol. 2016 Jul; 124(7):501-7. PMID: 26970244.
      View in: PubMed
    14. Renshaw AA, Gould EW. OCT4 staining increases the detection of lymphatic/vascular invasion in pure seminoma of the testis obscured by prominent lymphohistiocytic inflammation. Pathology. 2016 Apr; 48(3):210-3. PMID: 27020494.
      View in: PubMed
    15. Nakhleh RE, Nosé V, Renshaw A, McCrory D, Fatheree L. In Reply. Arch Pathol Lab Med. 2016 Jan; 140(1):9-10. PMID: 26717052.
      View in: PubMed
    16. Renshaw AA, Gould EW. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Pathology. 2016 Jan; 48(1):25-9. PMID: 27020205.
      View in: PubMed
    17. Vaickus LJ, Wilbur DC, Sweeney BJ, Renshaw AA. Young investigator challenge: Comparison of 2 different methods of manual slide screening in semiautomated gynecologic cytology. Cancer Cytopathol. 2015 Nov; 123(11):650-8. PMID: 26769586.
      View in: PubMed
    18. D'Amico AV, Chen MH, Renshaw A, Loffredo M, Kantoff PW. Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer. JAMA. 2015 Sep 22-29; 314(12):1291-3. PMID: 26393854.
      View in: PubMed
    19. Nakhleh RE, Nosé V, Colasacco C, Fatheree LA, Lillemoe TJ, McCrory DC, Meier FA, Otis CN, Owens SR, Raab SS, Turner RR, Ventura CB, Renshaw AA. Interpretive Diagnostic Error Reduction in Surgical Pathology and Cytology: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center and the Association of Directors of Anatomic and Surgical Pathology. Arch Pathol Lab Med. 2016 Jan; 140(1):29-40. PMID: 25965939.
      View in: PubMed
    20. Renshaw AA, Gould EW, Tershakovec G. Gallbladders: another source of radiation in the histology laboratory. Am J Clin Pathol. 2015 Feb; 143(2):310-1. PMID: 25596260.
      View in: PubMed
    21. Renshaw AA, Gould EW. Reducing indeterminate thyroid FNAs. Cancer Cytopathol. 2015 Apr; 123(4):237-43. PMID: 25644425.
      View in: PubMed
    22. Renshaw AA, Cheville JC. Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma. Pathology. 2015 Jan; 47(1):34-7. PMID: 25474516.
      View in: PubMed
    23. Renshaw AA, Gould EW. Extended laboratory information system downtime: Implementing a backup laboratory information system in the cytology laboratory. Cancer Cytopathol. 2015 Jan; 123(1):5-6. PMID: 25399797.
      View in: PubMed
    24. Moriarty AT, Nayar R, Arnold T, Gearries L, Renshaw A, Thomas N, Souers R. The Tahoe Study: bias in the interpretation of Papanicolaou test results when human papillomavirus status is known. Arch Pathol Lab Med. 2014 Sep; 138(9):1182-5. PMID: 25171700.
      View in: PubMed
    25. Keane FK, Chen MH, Zhang D, Loffredo MJ, Kantoff PW, Renshaw AA, D'Amico AV. The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease. Cancer. 2014 Jun 15; 120(12):1787-93. PMID: 24604289.
      View in: PubMed
    26. Martin NE, Chen MH, Beard CJ, Nguyen PL, Loffredo MJ, Renshaw AA, Kantoff PW, D'Amico AV. Natural history of untreated prostate specific antigen radiorecurrent prostate cancer in men with favorable prognostic indicators. Prostate Cancer. 2014; 2014:912943. PMID: 24701353; PMCID: PMC3950926.
      View in: PubMed, PubMed Central
    27. Renshaw SA, Mena-Allauca M, Touriz M, Renshaw A, Gould EW. The impact of template format on the completeness of surgical pathology reports. Arch Pathol Lab Med. 2014 Jan; 138(1):121-4. PMID: 24377820.
      View in: PubMed
    28. Renshaw AA, Gould EW. Reducing false-negative and false-positive diagnoses in anatomic pathology consultation material. Arch Pathol Lab Med. 2013 Dec; 137(12):1770-3. PMID: 24283857.
      View in: PubMed
    29. Vivero M, Renshaw AA, Krane JF. Influence of descriptive terminology on management of atypical thyroid fine-needle aspirates. Cancer Cytopathol. 2014 Mar; 122(3):175-81. PMID: 24203313.
      View in: PubMed
    30. Renshaw AA, Gould EW. Should "indeterminate" diagnoses be used for thyroid fine-needle aspirates of nodules smaller than 1 cm? Arch Pathol Lab Med. 2013 Nov; 137(11):1627-9. PMID: 24168500.
      View in: PubMed
    31. Renshaw AA. Intraoperative diagnosis miscommunication: an opportunity for improvement. Am J Clin Pathol. 2013 Nov; 140(5):608-9. PMID: 24124138.
      View in: PubMed
    32. Renshaw AA, Birdsong GG. Changing the cytology laboratory information system to improve cytology performance. Cancer Cytopathol. 2014 Feb; 122(2):87-91. PMID: 24039189.
      View in: PubMed
    33. Renshaw AA, Gould EW. Increasing agreement over time in interlaboratory anatomic pathology consultation material. Am J Clin Pathol. 2013 Aug; 140(2):215-8. PMID: 23897257.
      View in: PubMed
    34. Renshaw A, Gould E. The authors' reply. Am J Clin Pathol. 2013 Aug; 140(2):280. PMID: 23897267.
      View in: PubMed
    35. Renshaw A, Elsheikh TM. A validation study of the Focalpoint GS imaging system for gynecologic cytology screening. Cancer Cytopathol. 2013 Dec; 121(12):737-8. PMID: 23843282.
      View in: PubMed
    36. Renshaw AA, Gould EW. Impact of immediate access to the electronic medical record on anatomic pathology performance. Am J Clin Pathol. 2013 Jul; 140(1):109-11. PMID: 23765541.
      View in: PubMed
    37. Renshaw A, Gould E. The authors' reply. Am J Clin Pathol. 2013 Jun; 139(6):831. PMID: 23829000.
      View in: PubMed
    38. Renshaw AA, Elsheikh TM. The value of expert review in prospective trials of automated assisted screening devices. Diagn Cytopathol. 2014 Feb; 42(2):117-9. PMID: 23636929.
      View in: PubMed
    39. Renshaw AA, Gould EW. Thrombocytosis is associated with Mycobacterium tuberculosis infection and positive acid-fast stains in granulomas. Am J Clin Pathol. 2013 May; 139(5):584-6. PMID: 23596109.
      View in: PubMed
    40. Renshaw AA, Elsheikh TM. Assessment of manual workload limits in gynecologic cytology: reconciling data from 3 major prospective trials of automated screening devices. Am J Clin Pathol. 2013 Apr; 139(4):428-33. PMID: 23525612.
      View in: PubMed
    41. Jo VY, Renshaw AA, Krane JF. Relative sensitivity of thyroid fine-needle aspiration by tumor type and size. Diagn Cytopathol. 2013 Oct; 41(10):871-5. PMID: 23447387.
      View in: PubMed
    42. Renshaw AA, Drago B, Toraya N, Gould EW. Respiratory syncytial virus infection is strongly correlated with decreased mean platelet volume. Int J Infect Dis. 2013 Sep; 17(9):e678-80. PMID: 23485431.
      View in: PubMed
    43. Renshaw AA, Krane JF. Can changing the terminology for benign aspirates reduce the atypia of undetermined significance/follicular lesion of undetermined significance rate in thyroid fine-needle aspirates? Cancer Cytopathol. 2013 Apr; 121(4):175-8. PMID: 23132809.
      View in: PubMed
    44. Renshaw SA, Gupta S, Campos M, Hodes L, Renshaw AA, Gould EW. The addition of RPMI significantly improves the cellularity of cerebrospinal fluid cytology specimens over time. Cancer Cytopathol. 2013 May; 121(5):271-4. PMID: 23132821.
      View in: PubMed
    45. Renshaw AA, Gould EW. Submitting the entire gallbladder in cases of dysplasia is not justified. Am J Clin Pathol. 2012 Sep; 138(3):374-6. PMID: 22912353.
      View in: PubMed
    46. Renshaw AA. 88172 is more than counting cells: ensuring the quality of immediate assessment of fine-needle aspiration material. Am J Clin Pathol. 2012 Jul; 138(1):27-8. PMID: 22706854.
      View in: PubMed
    47. Tseng YD, Chen MH, Beard CJ, Martin NE, Orio PF, Loffredo M, Renshaw AA, Choueiri TK, Hu JC, Kantoff PW, D'Amico AV, Nguyen PL. Posttreatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality. J Urol. 2012 Jun; 187(6):2068-73. PMID: 22498212.
      View in: PubMed
    48. VanderLaan PA, Renshaw AA, Krane JF. Atypia of undetermined significance and nondiagnostic rates in The Bethesda System for Reporting Thyroid Cytopathology are inversely related. Am J Clin Pathol. 2012 Mar; 137(3):462-5. PMID: 22338059.
      View in: PubMed
    49. Renshaw A, Gould EW. Quality assurance measures for critical diagnoses in anatomic pathology. Am J Clin Pathol. 2012 Mar; 137(3):466-9. PMID: 22338060.
      View in: PubMed
    50. Elsheikh TM, Austin RM, Chhieng DF, Miller FS, Moriarty AT, Renshaw AA. American Society of Cytopathology workload recommendations for automated Pap test screening: developed by the productivity and quality assurance in the era of automated screening task force. Diagn Cytopathol. 2013 Feb; 41(2):174-8. PMID: 22351120.
      View in: PubMed
    51. Renshaw A. Using the electronic medical record to better define "no products of conception" as a critical value in anatomic pathology. Am J Clin Pathol. 2012 Jan; 137(1):121-3. PMID: 22180485.
      View in: PubMed
    52. Renshaw AA. Quality improvement in cytology: where do we go from here? Arch Pathol Lab Med. 2011 Nov; 135(11):1387-90. PMID: 22032562.
      View in: PubMed
    53. Renshaw SA, Gould EW, Renshaw AA. Unexpected expectations in critical values in anatomic pathology: improving agreement between pathologists and nonpathologists with the treatable immediately, life-threatening terminology. Arch Pathol Lab Med. 2011 Nov; 135(11):1391-3. PMID: 22032563.
      View in: PubMed
    54. Krane JF, Vanderlaan PA, Faquin WC, Renshaw AA. The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio: a proposed performance measure for reporting in The Bethesda System for thyroid cytopathology. Cancer Cytopathol. 2012 Apr 25; 120(2):111-6. PMID: 21919213.
      View in: PubMed
    55. Renshaw AA, Derhagopian RP, Gould EW. Cystic neutrophilic granulomatous mastitis: an underappreciated pattern strongly associated with gram-positive bacilli. Am J Clin Pathol. 2011 Sep; 136(3):424-7. PMID: 21846918.
      View in: PubMed
    56. Fischer AH, Cibas ES, Howell LP, Kurian EM, Laucirica R, Moriarty AT, Renshaw AA, Zakowski MF, Young NA. Role of cytology in the management of non-small-cell lung cancer. J Clin Oncol. 2011 Aug 20; 29(24):3331-2; author reply 3332-3. PMID: 21768461.
      View in: PubMed
    57. Renshaw AA. Significance of repeatedly nondiagnostic thyroid fine-needle aspirations. Am J Clin Pathol. 2011 May; 135(5):750-2. PMID: 21502429.
      View in: PubMed
    58. Renshaw AA. Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: distinct patterns and associated risk of malignancy. Cancer Cytopathol. 2011 Oct 25; 119(5):322-7. PMID: 21442771.
      View in: PubMed
    59. Renshaw AA. Fine-needle aspirations of papillary carcinoma with oncocytic features: an expanded cytologic and histologic profile. Cancer Cytopathol. 2011 Aug 25; 119(4):247-53. PMID: 21400667.
      View in: PubMed
    60. Clayton AC, Wasserman PG, Souers RJ, Chmara BA, Renshaw A, Wilbur DC, Moriarty AT. The multiple faces of carcinoid tumor: performance characteristics of low-grade neuroendocrine carcinoma metastatic to the liver in an educational interlaboratory slide comparison program. Arch Pathol Lab Med. 2011 Mar; 135(3):354-60. PMID: 21366460.
      View in: PubMed
    61. Renshaw AA, Elsheikh TM. Low grade squamous intraepithelial lesion, epithelial cell abnormality-adjusted workload, and the ThinPrep imaging system. Diagn Cytopathol. 2012 Aug; 40(8):698-700. PMID: 22807385.
      View in: PubMed
    62. Dudding N, Renshaw AA, Ellis K. Rapid pre-screening is more sensitive in liquid-based cytology than in conventional smears. Acta Cytol. 2011; 55(1):54-6. PMID: 21135523.
      View in: PubMed
    63. Renshaw AA. Non-diagnostic rates for thyroid fine needle aspiration are negatively correlated with positive for malignancy rates. Acta Cytol. 2011; 55(1):38-41. PMID: 21135520.
      View in: PubMed
    64. Renshaw AA, Elsheikh TM. Predicting screening sensitivity from workload in gynecologic cytology: a review. Diagn Cytopathol. 2011 Nov; 39(11):832-6. PMID: 21994194.
      View in: PubMed
    65. Renshaw AA. Histologic follow-up of nondiagnostic thyroid fine needle aspirations: implications for adequacy criteria. Diagn Cytopathol. 2012 May; 40 Suppl 1:E13-5. PMID: 22619153.
      View in: PubMed
    66. Renshaw AA, Elsheikh TM. HSIL, epithelial cell abnormality-adjusted workload, and the Thinprep imaging system. Diagn Cytopathol. 2012 Mar; 40(3):201-3. PMID: 22334521.
      View in: PubMed
    67. Ellis K, Renshaw AA, Dudding N. Individual estimated sensitivity and workload for manual screening of SurePath gynecologic cytology. Diagn Cytopathol. 2012 Feb; 40(2):95-7. PMID: 22246923.
      View in: PubMed
    68. Renshaw AA. Does a repeated benign aspirate change the risk of malignancy after an initial atypical thyroid fine-needle aspiration? Am J Clin Pathol. 2010 Nov; 134(5):788-92. PMID: 20959662.
      View in: PubMed
    69. Wilgenbusch H, Mueller G, Neal M, Renshaw AA. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device. Diagn Cytopathol. 2011 Nov; 39(11):818-21. PMID: 20949451.
      View in: PubMed
    70. Renshaw AA, Elsheikh TM. Sensitivity and workload for manual and automated gynecologic screening: best current estimates. Diagn Cytopathol. 2011 Sep; 39(9):647-50. PMID: 20945459.
      View in: PubMed
    71. Renshaw AA, Elsheikh TM. Controls in quality assessment in gynecologic cytology: A rational approach to workload limits for the ThinPrep imaging system. Diagn Cytopathol. 2010 Oct; 38(10):772-5. PMID: 20091901.
      View in: PubMed
    72. Renshaw MA, Gould EW, Renshaw A. Just say no to the use of no: alternative terminology for improving anatomic pathology reports. Arch Pathol Lab Med. 2010 Sep; 134(9):1250-2. PMID: 20807042.
      View in: PubMed
    73. Renshaw A. An estimate of risk of malignancy for a benign diagnosis in thyroid fine-needle aspirates. Cancer Cytopathol. 2010 Aug 25; 118(4):190-5. PMID: 20586117.
      View in: PubMed
    74. Renshaw AA. Should "atypical follicular cells" in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol. 2010 Aug 25; 118(4):186-9. PMID: 20586118.
      View in: PubMed
    75. Renshaw AA. UroVysion, urine cytology, and the College of American Pathologists: where should we go from here? Arch Pathol Lab Med. 2010 Aug; 134(8):1106-7. PMID: 20670128.
      View in: PubMed
    76. Renshaw AA, Kish R, Gould EW. Increasing radiation from sentinel node specimens in pathology over time. Am J Clin Pathol. 2010 Aug; 134(2):299-302. PMID: 20660335.
      View in: PubMed
    77. Velazquez EF, Amin MB, Epstein JI, Grignon DJ, Humphrey PA, Pettaway CA, Renshaw AA, Reuter VE, Srigley JR, Cubilla AL. Protocol for the examination of specimens from patients with carcinoma of the penis. Arch Pathol Lab Med. 2010 Jun; 134(6):923-9. PMID: 20524869.
      View in: PubMed
    78. Dudding N, Renshaw AA, Ellis K. Improved sensitivity over time with rapid prescreening in gynecologic cytology. Diagn Cytopathol. 2011 Jun; 39(6):428-30. PMID: 21574262.
      View in: PubMed
    79. Renshaw AA. Sensitivity of fine-needle aspiration for papillary carcinoma of the thyroid correlates with tumor size. Diagn Cytopathol. 2011 Jul; 39(7):471-4. PMID: 21695800.
      View in: PubMed
    80. Renshaw AA. Quantitative assessment of spray vs immersion fixation for thyroid fine-needle aspiration specimens. Am J Clin Pathol. 2010 May; 133(5):796-8. PMID: 20395528.
      View in: PubMed
    81. Elsheikh TM, Kirkpatrick JL, Cooper MK, Johnson ML, Hawkins AP, Renshaw AA. Increasing cytotechnologist workload above 100 slides per day using the ThinPrep imaging system leads to significant reductions in screening accuracy. Cancer Cytopathol. 2010 Apr 25; 118(2):75-82. PMID: 20151428.
      View in: PubMed
    82. Srigley JR, Amin MB, Delahunt B, Campbell SC, Chang A, Grignon DJ, Humphrey PA, Leibovich BC, Montironi R, Renshaw AA, Reuter VE. Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin. Arch Pathol Lab Med. 2010 Apr; 134(4):e25-30. PMID: 20367296.
      View in: PubMed
    83. Renshaw AA, Auger M, Birdsong G, Cibas ES, Henry M, Hughes JH, Moriarty A, Tench W, Wilbur DC, Elsheikh TM. ASC/SIL ratio for cytotechnologists: A survey of its utility in clinical practice. Diagn Cytopathol. 2010 Mar; 38(3):180-3. PMID: 19760762.
      View in: PubMed
    84. Elsheikh TM, Kirkpatrick JL, Fischer D, Herbert KD, Renshaw AA. Does the time of day or weekday affect screening accuracy? A pilot correlation study with cytotechnologist workload and abnormal rate detection using the ThinPrep Imaging System. Cancer Cytopathol. 2010 Feb 25; 118(1):41-6. PMID: 20099317.
      View in: PubMed
    85. Renshaw MA, Renshaw AA, Gould EW. Should pathologists send all or only selected slides for patient-requested interlaboratory second opinion? Am J Clin Pathol. 2009 Nov; 132(5):763-6. PMID: 19846819.
      View in: PubMed
    86. Wo JY, Chen MH, Nguyen PL, Renshaw AA, Loffredo MJ, Kantoff PW, D'Amico AV. Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence. J Clin Oncol. 2009 Dec 10; 27(35):6000-5. PMID: 19858385.
      View in: PubMed
    87. Nguyen PL, Chen MH, Beard CJ, Suh WW, Renshaw AA, Loffredo M, McMahon E, Kantoff PW, D'Amico AV. Radiation with or without 6 months of androgen suppression therapy in intermediate- and high-risk clinically localized prostate cancer: a postrandomization analysis by risk group. Int J Radiat Oncol Biol Phys. 2010 Jul 15; 77(4):1046-52. PMID: 19864082.
      View in: PubMed
    88. Brimo F, Renshaw AA, Deschenes M, Charbonneau M, Auger M. Improvement in the routine screening performance of cytotechnologists over time: a study using rapid prescreening. Cancer. 2009 Oct 25; 117(5):311-7. PMID: 19711473.
      View in: PubMed
    89. Renshaw AA, Brimo F, Auger M. Surrogate indicators of sensitivity in gynecologic cytology: can they be used to improve the measurement of sensitivity in the laboratory? Cytojournal. 2009 Oct 09; 6:19. PMID: 19876383; PMCID: PMC2762693.
      View in: PubMed, PubMed Central
    90. Srigley JR, Humphrey PA, Amin MB, Chang SS, Egevad L, Epstein JI, Grignon DJ, McKiernan JM, Montironi R, Renshaw AA, Reuter VE, Wheeler TM. Protocol for the examination of specimens from patients with carcinoma of the prostate gland. Arch Pathol Lab Med. 2009 Oct; 133(10):1568-76. PMID: 19792046.
      View in: PubMed
    91. Renshaw AA. Strategies for improving gynecologic cytology screening. Cancer. 2009 Jun 25; 117(3):151-3. PMID: 19618478.
      View in: PubMed
    92. Renshaw AA, Deschênes M, Auger M. ASC/SIL Ratio for Cytotechnologists: A surrogate marker of screening sensitivity. Am J Clin Pathol. 2009 Jun; 131(6):776-81. PMID: 19461082.
      View in: PubMed
    93. D'Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW. Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death. Int J Radiat Oncol Biol Phys. 2009 Sep 01; 75(1):10-5. PMID: 19395184.
      View in: PubMed
    94. Nguyen PL, Chen MH, Renshaw AA, Loffredo M, Kantoff PW, D'Amico AV. Survival following radiation and androgen suppression therapy for prostate cancer in healthy older men: implications for screening recommendations. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):337-41. PMID: 19395186.
      View in: PubMed
    95. Renshaw AA. Quality in pathology: of Deming, the Edsel, and Henry Ford. Am J Clin Pathol. 2009 Apr; 131(4):461-2. PMID: 19289580.
      View in: PubMed
    96. Nanda A, Chen MH, Renshaw AA, D'Amico AV. Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials. Int J Radiat Oncol Biol Phys. 2009 Aug 01; 74(5):1419-23. PMID: 19131185.
      View in: PubMed
    97. D'Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW. Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer. Cancer. 2008 Dec 15; 113(12):3290-7. PMID: 18980297.
      View in: PubMed
    98. Renshaw AA. Seeking a silver lining: improving the performance of gynecologic cytology in a lower volume setting. Cancer. 2008 Aug 25; 114(4):222-4. PMID: 18512223.
      View in: PubMed
    99. Deschenes M, Renshaw AA, Auger M. Measuring the significance of workload on performance of cytotechnologists in gynecologic cytology: a study using rapid prescreening. Cancer. 2008 Jun 25; 114(3):149-54. PMID: 18412150.
      View in: PubMed
    100. Renshaw AA. Choosing battles or excuses in gynecologic cytology. Cancer. 2008 Jun 25; 114(3):141-3. PMID: 18442041.
      View in: PubMed
    101. D'Amico AV, Chen MH, Renshaw AA, Loffredo B, Kantoff PW. Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy. J Clin Oncol. 2008 Jun 20; 26(18):2979-83. PMID: 18565884.
      View in: PubMed
    102. Pitman MB, Abele J, Ali SZ, Duick D, Elsheikh TM, Jeffrey RB, Powers CN, Randolph G, Renshaw A, Scoutt L. Techniques for thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008 Jun; 36(6):407-24. PMID: 18478608.
      View in: PubMed
    103. D'Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. JAMA. 2008 Jan 23; 299(3):289-95. PMID: 18212313.
      View in: PubMed
    104. Renshaw AA. Reporting risk of malignancy/dysplasia in cytology: a potential way to improve communication, if not reputation. Cancer. 2007 Dec 25; 111(6):465-6. PMID: 17924580.
      View in: PubMed
    105. D'Amico AV, Renshaw AA, Loffredo B, Chen MH. Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy. Cancer. 2007 Oct 15; 110(8):1723-8. PMID: 17828774.
      View in: PubMed
    106. Patel AA, Chen MH, Renshaw AA, D'Amico AV. PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5. JAMA. 2007 Oct 03; 298(13):1533-8. PMID: 17911498.
      View in: PubMed
    107. Renshaw AA, Pinnar N. Comparison of thyroid fine-needle aspiration and core needle biopsy. Am J Clin Pathol. 2007 Sep; 128(3):370-4. PMID: 17709309.
      View in: PubMed
    108. Nguyen PL, Chen MH, Renshaw AA, Sussman B, D'Amico AV. Effect of definition of preradiotherapy prostate-specific antigen velocity on its association with prostate cancer-specific mortality and all-cause mortality. Urology. 2007 Aug; 70(2):288-93. PMID: 17826491.
      View in: PubMed
    109. Renshaw A. Complaining about quality assurance in gynecologic cytology: a window that is now closing. Cancer. 2007 Jun 25; 111(3):141-2. PMID: 17516436.
      View in: PubMed
    110. Efstathiou JA, Chen MH, Renshaw AA, Loffredo MJ, D'Amico AV. Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer. Cancer. 2007 Apr 15; 109(8):1493-8. PMID: 17340594.
      View in: PubMed
    111. Krejcarek SC, Chen MH, Renshaw AA, Loffredo M, Sussman B, D'Amico AV. Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer. Urology. 2007 Mar; 69(3):515-9. PMID: 17382156.
      View in: PubMed
    112. Renshaw AA, Kish R, Gould EW. The value of inking breast cores to reduce specimen mix-up. Am J Clin Pathol. 2007 Feb; 127(2):271-2. PMID: 17210528.
      View in: PubMed
    113. Renshaw AA, Gould EW. Measuring errors in surgical pathology in real-life practice: defining what does and does not matter. Am J Clin Pathol. 2007 Jan; 127(1):144-52. PMID: 17145620.
      View in: PubMed
    114. Renshaw AA. Improving consensus on the cause of cytologic-histologic discrepancy: searching for quality assurance methods that work. Am J Clin Pathol. 2006 Dec; 126(6):831-2. PMID: 17074691.
      View in: PubMed
    115. Renshaw AA, Kish R, Gould EW. Sessile serrated adenoma is associated with acute appendicitis in patients 30 years or older. Am J Clin Pathol. 2006 Dec; 126(6):875-7. PMID: 17074693.
      View in: PubMed
    116. Renshaw AA, Hughes JH, Wang E, Haja J, Wilbur D, Henry MR, Moriarty AT. Leukemia/lymphoma in cerebrospinal fluid: distinguishing between cases that performed well and poorly in the College of American Pathologists Interlaboratory Comparison Program in Non-gynecologic Cytology. Arch Pathol Lab Med. 2006 Dec; 130(12):1762-5. PMID: 17149947.
      View in: PubMed
    117. D'Amico AV, Hui-Chen M, Renshaw AA, Sussman B, Roehl KA, Catalona WJ. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer. J Urol. 2006 Dec; 176(6 Pt 2):S11-5. PMID: 17084157.
      View in: PubMed
    118. Petit JH, Chen MH, Loffredo M, Sussman B, Renshaw AA, D'Amico AV. Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer. Cancer. 2006 Nov 01; 107(9):2180-5. PMID: 17009323.
      View in: PubMed
    119. Renshaw AA, Gould EW. Comparison of disagreement and amendment rates by tissue type and diagnosis: identifying cases for directed blinded review. Am J Clin Pathol. 2006 Nov; 126(5):736-9. PMID: 17050070.
      View in: PubMed
    120. Renshaw AA, Haja JC, Neal MH, Wilbur DC. Distinguishing carcinoid tumor of the mediastinum from thymoma: correlating cytologic features and performance in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytopathology. Arch Pathol Lab Med. 2006 Nov; 130(11):1612-5. PMID: 17076522.
      View in: PubMed
    121. Renshaw AA, Mody DR, Walsh M, Bentz JS, Colgan TJ. The significance of certification in liquid-based cytology and performance in the college of american pathologists interlaboratory comparison program in cervicovaginal cytopathology. Arch Pathol Lab Med. 2006 Sep; 130(9):1269-72. PMID: 16948509.
      View in: PubMed
    122. D'Amico AV, Loffredo M, Renshaw AA, Loffredo B, Chen MH. Six-month androgen suppression plus radiation therapy compared with radiation therapy alone for men with prostate cancer and a rapidly increasing pretreatment prostate-specific antigen level. J Clin Oncol. 2006 Sep 01; 24(25):4190-5. PMID: 16943536.
      View in: PubMed
    123. Renshaw A. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy. Cancer. 2006 Aug 25; 108(4):267; author reply 268. PMID: 16671112.
      View in: PubMed
    124. Renshaw AA, Walsh MK, Blond B, Moriarty AT, Mody DR, Colgan TJ. Robustness of validation criteria in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2006 Aug; 130(8):1119-22. PMID: 16879011.
      View in: PubMed
    125. Renshaw AA, Derhagopian RP, Martinez P, Gould EW. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Am J Clin Pathol. 2006 Aug; 126(2):310-3. PMID: 16891208.
      View in: PubMed
    126. Srigley JR, Amin MB, Epstein JI, Grignon DJ, Humphrey PA, Renshaw AA, Wheeler TM. Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland. Arch Pathol Lab Med. 2006 Jul; 130(7):936-46. PMID: 16831046.
      View in: PubMed
    127. Beard C, Schultz D, Loffredo M, Cote K, Renshaw AA, Hurwitz MD, D'Amico AV. Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Oct 01; 66(2):403-7. PMID: 16765530.
      View in: PubMed
    128. Renshaw AA, Gould EW. Correlation of workload with disagreement and amendment rates in surgical pathology and nongynecologic cytology. Am J Clin Pathol. 2006 Jun; 125(6):820-2. PMID: 16690479.
      View in: PubMed
    129. D'Amico AV, Kantoff P, Loffredo M, Renshaw AA, Loffredo B, Chen MH. Predictors of mortality after prostate-specific antigen failure. Int J Radiat Oncol Biol Phys. 2006 Jul 01; 65(3):656-60. PMID: 16682147.
      View in: PubMed
    130. Renshaw AA, Gould EW. Measuring the value of review of pathology material by a second pathologist. Am J Clin Pathol. 2006 May; 125(5):737-9. PMID: 16707375.
      View in: PubMed
    131. Renshaw AA. Comparing methods to measure error in gynecologic cytology and surgical pathology. Arch Pathol Lab Med. 2006 May; 130(5):626-9. PMID: 16683876.
      View in: PubMed
    132. Renshaw AA, Wang E, Haja J, Wilbur D, Henry MR, Hughes JH. Fine-needle aspiration of papillary thyroid carcinoma: distinguishing between cases that performed well and those that performed poorly in the College of American Pathologists Nongynecologic Cytology Program. Arch Pathol Lab Med. 2006 Apr; 130(4):452-5. PMID: 16594737.
      View in: PubMed
    133. Renshaw AA, Mody DR, Styer P, Schwartz M, Ducatman B, Colgan TJ. Papanicolaou tests with mixed high-grade and low-grade squamous intraepithelial lesion features: distinct performance in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytopathology. Arch Pathol Lab Med. 2006 Apr; 130(4):456-9. PMID: 16594738.
      View in: PubMed
    134. Renshaw AA, Mody DR, Wang E, Haja J, Colgan TJ. Hyperchromatic crowded groups in cervical cytology--differing appearances and interpretations in conventional and ThinPrep preparations: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2006 Mar; 130(3):332-6. PMID: 16519560.
      View in: PubMed
    135. Renshaw AA. Making the cut: what can be regularly and reliably identified in gynecologic cytology? Diagn Cytopathol. 2006 Mar; 34(3):181-3. PMID: 16470865.
      View in: PubMed
    136. Renshaw AA. Comparison of ureteral washing and biopsy specimens in the community setting. Cancer. 2006 Feb 25; 108(1):45-8. PMID: 16302250.
      View in: PubMed
    137. Renshaw AA, Wang E, Wilbur D, Hughes JH, Haja J, Henry MR. Interobserver agreement on microfollicles in thyroid fine-needle aspirates. Arch Pathol Lab Med. 2006 Feb; 130(2):148-52. PMID: 16454552.
      View in: PubMed
    138. Renshaw AA, Schwartz MR, Wang E, Haja J, Hughes JH. Cytologic features of adenocarcinoma, not otherwise specified, in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. Arch Pathol Lab Med. 2006 Jan; 130(1):23-6. PMID: 16390233.
      View in: PubMed
    139. Renshaw AA, Haja J, Wilbur DC, Miller TR. Fine-needle aspirates of hepatocellular carcinoma that are misclassified as adenocarcinoma: correlating cytologic features and performance in the College of American Pathologists Nongynecologic Cytology Program. Arch Pathol Lab Med. 2006 Jan; 130(1):19-22. PMID: 16390232.
      View in: PubMed
    140. Renshaw AA, Gould EW. Comparison of disagreement and error rates for three types of interdepartmental consultations. Am J Clin Pathol. 2005 Dec; 124(6):878-82. PMID: 16416737.
      View in: PubMed
    141. Dvorak T, Chen MH, Renshaw AA, Loffredo M, Richie JP, D'Amico AV. Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancer. Urology. 2005 Nov; 66(5):1024-8. PMID: 16286117.
      View in: PubMed
    142. Beard C, Chen MH, Cote K, Loffredo M, Renshaw A, Hurwitz M, D'Amico AV. Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancer. Urology. 2005 Nov; 66(5):1020-3. PMID: 16286116.
      View in: PubMed
    143. Renshaw AA, Holladay EB, Geils KB. Results of multiple-slide, blinded review of Papanicolaou slides in the context of litigation. Determining what can be detected regularly and reliably. Cancer. 2005 Oct 25; 105(5):263-9. PMID: 16015638.
      View in: PubMed
    144. Renshaw AA, Haja J, Wilbur DC, Miller TR. Fine-needle aspirates of adenocarcinoma/metastatic carcinoma that resemble hepatocellular carcinoma: correlating cytologic features and performance in the College of American Pathologists Nongynecologic Cytology Program. Arch Pathol Lab Med. 2005 Oct; 129(10):1217-21. PMID: 16196506.
      View in: PubMed
    145. Renshaw AA, Mody DR, Wang E, Wilbur DC, Colgan TJ. Measuring the significance of participant evaluation of acceptability of cases in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. Arch Pathol Lab Med. 2005 Sep; 129(9):1093-6. PMID: 16119978.
      View in: PubMed
    146. McAleer SJ, Schultz D, Whittington R, Malkowicz SB, Renshaw A, Wein A, Richie JP, D'Amico AV. PSA outcome following radical prostatectomy for patients with localized prostate cancer stratified by prostatectomy findings and the preoperative PSA level. Urol Oncol. 2005 Sep-Oct; 23(5):311-7. PMID: 16144663.
      View in: PubMed
    147. Renshaw AA, Henry MR, Birdsong GG, Wang E, Haja J, Hughes JH. Cytologic features of squamous cell carcinoma in conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology. Arch Pathol Lab Med. 2005 Sep; 129(9):1097-9. PMID: 16119979.
      View in: PubMed
    148. Renshaw AA. Papillary carcinoma of the thyroid
      View in: PubMed
    149. D'Amico AV, Renshaw AA, Sussman B, Chen MH. Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA. 2005 Jul 27; 294(4):440-7. PMID: 16046650.
      View in: PubMed
    150. Snyder TM, Renshaw AA, Styer PE, Mody DR, Colgan TJ. Altered recognition of reparative changes in ThinPrep specimens in the College of American Pathologists Gynecologic Cytology Program. Arch Pathol Lab Med. 2005 Jul; 129(7):861-5. PMID: 15974808.
      View in: PubMed
    151. Renshaw AA. Proficiency testing: planning for the future. Cancer. 2005 Jun 25; 105(3):124-5. PMID: 15830400.
      View in: PubMed
    152. Renshaw AA, Prey MU, Hodes L, Weisson M, Haja J, Moriarty AT. Cytologic features of high-grade squamous intraepithelial lesion in conventional slides: what is the difference between cases that perform well and those that perform poorly? Arch Pathol Lab Med. 2005 Jun; 129(6):733-5. PMID: 15913418.
      View in: PubMed
    153. Nguyen PL, Whittington R, Koo S, Schultz D, Cote KB, Loffredo M, McMahon E, Renshaw AA, Tomaszewski JE, D'Amico AV. The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma. Cancer. 2005 May 15; 103(10):2053-9. PMID: 15816048.
      View in: PubMed
    154. Renshaw AA, Haja J, Lozano RL, Wilbur DC. Distinguishing carcinoid tumor from small cell carcinoma of the lung: correlating cytologic features and performance in the College of American Pathologists Non-Gynecologic Cytology Program. Arch Pathol Lab Med. 2005 May; 129(5):614-8. PMID: 15859631.
      View in: PubMed
    155. Renshaw AA, Wang E, Mody DR, Wilbur DC, Davey DD, Colgan TJ. Measuring the significance of field validation in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology: how good are the experts? Arch Pathol Lab Med. 2005 May; 129(5):609-13. PMID: 15859630.
      View in: PubMed
    156. Renshaw AA, Voytek TM, Haja J, Wilbur DC. Distinguishing small cell carcinoma from non-small cell carcinoma of the lung: correlating cytologic features and performance in the College of American Pathologists Non-Gynecologic Cytology Program. Arch Pathol Lab Med. 2005 May; 129(5):619-23. PMID: 15859632.
      View in: PubMed
    157. Faquin WC, Cibas ES, Renshaw AA. "Atypical" cells in fine-needle aspiration biopsy specimens of benign thyroid cysts. Cancer. 2005 Apr 25; 105(2):71-9. PMID: 15662703.
      View in: PubMed
    158. Renshaw A. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer. 2005 Mar 15; 103(6):1317-8; author reply 1318. PMID: 15674850.
      View in: PubMed
    159. Lin DD, Schultz D, Renshaw AA, Rubin MA, Richie JP, D'Amico AV. Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era. Urology. 2005 Mar; 65(3):528-32. PMID: 15780370.
      View in: PubMed
    160. Hughes JH, Young NA, Wilbur DC, Renshaw AA, Mody DR. Fine-needle aspiration of pulmonary hamartoma: a common source of false-positive diagnoses in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med. 2005 Jan; 129(1):19-22. PMID: 15628903.
      View in: PubMed
    161. Renshaw AA, Dubray-Benstein B, Haja J, Hughes JH. Cytologic features of low-grade squamous intraepithelial lesion in thinprep papanicolaou test slides and conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2005 Jan; 129(1):23-5. PMID: 15628904.
      View in: PubMed
    162. Renshaw AA. Quality assessment in the age of machine-aided cervical cytology screening. Cancer. 2004 Dec 25; 102(6):345-7. PMID: 15540251.
      View in: PubMed
    163. Renshaw AA, Gould EW. Concentrated smear technique for examining sentinel lymph nodes of the breast at the time of frozen section. Am J Clin Pathol. 2004 Dec; 122(6):944-6. PMID: 15539388.
      View in: PubMed
    164. D'Amico AV, Renshaw AA, Cote K, Hurwitz M, Beard C, Loffredo M, Chen MH. Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease. J Clin Oncol. 2004 Sep 15; 22(18):3726-32. PMID: 15365069.
      View in: PubMed
    165. Renshaw AA. Minimal (< or =0.1 cm) invasive carcinoma in breast core needle biopsies. Incidence, sampling, associated findings, and follow-up. Arch Pathol Lab Med. 2004 Sep; 128(9):996-9. PMID: 15335264.
      View in: PubMed
    166. D'Amico AV, Manola J, Loffredo M, Renshaw AA, DellaCroce A, Kantoff PW. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA. 2004 Aug 18; 292(7):821-7. PMID: 15315996.
      View in: PubMed
    167. Renshaw A. The natural history of incidentally detected small renal masses. Cancer. 2004 Aug 01; 101(3):650; author reply 651-2. PMID: 15274080.
      View in: PubMed
    168. Renshaw AA, Derhagopian RP, Tizol-Blanco DM, Gould EW. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Am J Clin Pathol. 2004 Aug; 122(2):217-21. PMID: 15323138.
      View in: PubMed
    169. Nguyen PL, Schultz D, Renshaw AA, Vollmer RT, Welch WR, Cote K, D'Amico AV. The impact of pathology review on treatment recommendations for patients with adenocarcinoma of the prostate. Urol Oncol. 2004 Jul-Aug; 22(4):295-9. PMID: 15283886.
      View in: PubMed
    170. Renshaw AA, Schulte MA, Plott E, Dubray-Benstein B, Cobb CJ, Lozano RL, Neal MH, Hughes JH, Young NA, Prey M. Cytologic features of high-grade squamous intraepithelial lesion in ThinPrep Papanicolaou test slides: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2004 Jul; 128(7):746-8. PMID: 15214829.
      View in: PubMed
    171. Renshaw AA, Young ML, Holladay EB. Blinded review of Papanicolaou smears in the context of litigation. Cancer. 2004 Jun 25; 102(3):136-41. PMID: 15211471.
      View in: PubMed
    172. Nguyen PL, Whittington R, Koo S, Schultz D, Cote KB, Loffredo M, Tempany CM, Titelbaum DS, Schnall MD, Renshaw AA, Tomaszewski JE, D'Amico AV. Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Jun 01; 59(2):400-5. PMID: 15145155.
      View in: PubMed
    173. D'Amico AV, Moul JW, Carroll PR, Cote K, Sun L, Lubeck D, Renshaw AA, Loffredo M, Chen MH. Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure. J Natl Cancer Inst. 2004 Apr 07; 96(7):509-15. PMID: 15069112.
      View in: PubMed
    174. Renshaw AA, Dubray-Benstein B, Cobb CJ, Lozano RL, Neal MH, Prey M, Schulte MA. Cytologic features of squamous cell carcinoma in ThinPrep slides: evaluation of cases that performed poorly versus those that performed well in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2004 Apr; 128(4):403-5. PMID: 15043450.
      View in: PubMed
    175. Renshaw AA. Increased cervical cancer screening intervals: a risky investment? Diagn Cytopathol. 2004 Mar; 30(3):137-8. PMID: 14986290.
      View in: PubMed
    176. Renshaw AA, Mody DR, Lozano RL, Volk EE, Walsh MK, Davey DD, Birdsong GG. Detection of adenocarcinoma in situ of the cervix in Papanicolaou tests: comparison of diagnostic accuracy with other high-grade lesions. Arch Pathol Lab Med. 2004 Feb; 128(2):153-7. PMID: 14736290.
      View in: PubMed
    177. Bloom KD, Richie JP, Schultz D, Renshaw A, Saegaert T, D'amico AV. Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors. Urology. 2004 Feb; 63(2):333-6. PMID: 14972484.
      View in: PubMed
    178. Renshaw AA, Young NA, Birdsong GG, Styer PE, Davey DD, Mody DR, Colgan TJ. Comparison of performance of conventional and ThinPrep gynecologic preparations in the College of American Pathologists Gynecologic Cytology Program. Arch Pathol Lab Med. 2004 Jan; 128(1):17-22. PMID: 14692817.
      View in: PubMed
    179. Beard CJ, Chen MH, Cote K, Loffredo M, Renshaw AA, Hurwitz M, D'Amico AV. Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer. Int J Radiat Oncol Biol Phys. 2004 Jan 01; 58(1):19-24. PMID: 14697416.
      View in: PubMed
    180. D'Amico AV, Cote K, Loffredo M, Renshaw AA, Schultz D. Determinants of prostate cancer specific survival following radiation therapy during the prostate specific antigen era. J Urol. 2003 Dec; 170(6 Pt 2):S42-6; discussion S46-7. PMID: 14610409.
      View in: PubMed
    181. Renshaw AA, Davey DD, Birdsong GG, Walsh M, Styer PE, Mody DR, Colgan TJ. Precision in gynecologic cytologic interpretation: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 2003 Nov; 127(11):1413-20. PMID: 14567728.
      View in: PubMed
    182. Renshaw A. Misclassification of cytologic diagnoses in patients with follicular lesions or follicular neoplasms of the thyroid gland. Cancer. 2003 Oct 25; 99(5):318-9; author reply 319-20. PMID: 14579299.
      View in: PubMed
    183. Renshaw AA. Fine-needle aspiration of Hurthle cell lesions: making the best of what consumers want. Diagn Cytopathol. 2003 Oct; 29(4):183-4. PMID: 14506668.
      View in: PubMed
    184. Renshaw AA. Rescreening in cervical cytology for quality control. When bad data is worse than no data or what works, what doesn't, and why. Clin Lab Med. 2003 Sep; 23(3):695-708. PMID: 14560535.
      View in: PubMed
    185. Sanghani MV, Schultz D, Tempany CM, Titelbaum D, Renshaw AA, Loffredo M, Cote K, McMahon B, D'Amico AV. Quantifying the change in endorectal magnetic resonance imaging-defined tumor volume during neoadjuvant androgen suppression therapy in patients with prostate cancer. Urology. 2003 Sep; 62(3):487-91. PMID: 12946752.
      View in: PubMed
    186. Renshaw AA, Schultz D, Cote K, Loffredo M, Ziemba DE, D'Amico AV. Accurate Gleason grading of prostatic adenocarcinoma in prostate needle biopsies by general pathologists. Arch Pathol Lab Med. 2003 Aug; 127(8):1007-8. PMID: 12873176.
      View in: PubMed
    187. Renshaw A. Ethical issues in anatomic pathology. Am J Surg Pathol. 2003 Aug; 27(8):1173-4; author reply 1175. PMID: 12914008.
      View in: PubMed
    188. Kukoski R, Blonigen B, Macri E, Renshaw AA, Hoffman M, Loda M, Datta MW. p27 and cyclin E/D2 associations in testicular germ cell tumors: implications for tumorigenesis. Appl Immunohistochem Mol Morphol. 2003 Jun; 11(2):138-43. PMID: 12777997.
      View in: PubMed
    189. Renshaw AA, Cartagena N, Granter SR, Gould EW. Agreement and error rates using blinded review to evaluate surgical pathology of biopsy material. Am J Clin Pathol. 2003 Jun; 119(6):797-800. PMID: 12817425.
      View in: PubMed
    190. D'Amico AV, Cote K, Loffredo M, Renshaw AA, Chen MH. Pretreatment predictors of time to cancer specific death after prostate specific antigen failure. J Urol. 2003 Apr; 169(4):1320-4. PMID: 12629352.
      View in: PubMed
    191. Lee AK, Doytchinova T, Chen MH, Renshaw AA, Weinstein M, Richie JP, D'Amico AV. Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core? Urol Oncol. 2003 Mar-Apr; 21(2):123-7. PMID: 12856640.
      View in: PubMed
    192. Renshaw AA, Young ML, Jiroutek MR. How many cases need to be reviewed to compare performance in surgical pathology? Am J Clin Pathol. 2003 Mar; 119(3):388-91. PMID: 12645341.
      View in: PubMed
    193. D'Amico AV, Cote K, Loffredo M, Renshaw AA, Chen MH. Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma. Cancer. 2003 Jan 01; 97(1):56-62. PMID: 12491505.
      View in: PubMed
    194. D'Amico AV, Cote K, Loffredo M, Renshaw AA, Schultz D. Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer. J Clin Oncol. 2002 Dec 01; 20(23):4567-73. PMID: 12454114.
      View in: PubMed
    195. Das P, Chen MH, Valentine K, Lopes L, Cormack RA, Renshaw AA, Tempany CM, Kumar S, D'Amico AV. Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce. Int J Radiat Oncol Biol Phys. 2002 Nov 01; 54(3):698-702. PMID: 12377320.
      View in: PubMed
    196. Renshaw AA. How closely do thyroid fine-needle aspirates need to be screened? Diagn Cytopathol. 2002 Nov; 27(5):259-60. PMID: 12411987.
      View in: PubMed
    197. Renshaw AA. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria. Cancer. 2002 Oct 25; 96(5):261-6. PMID: 12378592.
      View in: PubMed
    198. Renshaw AA. Evidence-based criteria for adequacy in thyroid fine-needle aspiration. Am J Clin Pathol. 2002 Oct; 118(4):518-21. PMID: 12375637.
      View in: PubMed
    199. D'Amico AV, Chen MH, Oh-Ung J, Renshaw AA, Cote K, Loffredo M, Richie JP. Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era. Int J Radiat Oncol Biol Phys. 2002 Oct 01; 54(2):436-41. PMID: 12243819.
      View in: PubMed
    200. Renshaw AA. Subclassification of renal cell neoplasms: an update for the practising pathologist. Histopathology. 2002 Oct; 41(4):283-300. PMID: 12383210.
      View in: PubMed
    201. Ung JO, Richie JP, Chen MH, Renshaw AA, D'Amico AV. Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. Urology. 2002 Sep; 60(3):458-63. PMID: 12350484.
      View in: PubMed
    202. Yoon JH, Chen MH, Renshaw AA, Richie JP, D'Amico AV. Predictive factor analysis as the basis for the clinical utility of percent positive prostate biopsies in patients with intermediate-risk prostate cancer. Urology. 2002 Sep; 60(3):454-7. PMID: 12350483.
      View in: PubMed
    203. Renshaw AA. Measuring sensitivity in gynecologic cytology: a review. Cancer. 2002 Aug 25; 96(4):210-7. PMID: 12209662.
      View in: PubMed
    204. Renshaw AA. "Histiocytoid" cells in fine-needle aspirations of papillary carcinoma of the thyroid: frequency and significance of an under-recognized cytologic pattern. Cancer. 2002 Aug 25; 96(4):240-3. PMID: 12209666.
      View in: PubMed
    205. Renshaw A. Interinstitutional review of thyroid fine-needle aspirations. Diagn Cytopathol. 2002 Aug; 27(2):128-9; author reply 130. PMID: 12203883.
      View in: PubMed
    206. Renshaw AA, Pinnar NE, Jiroutek MR, Young ML. Blinded review as a method for quality improvement in surgical pathology. Arch Pathol Lab Med. 2002 Aug; 126(8):961-3. PMID: 12171496.
      View in: PubMed
    207. Renshaw AA. Focal features of papillary carcinoma of the thyroid in fine-needle aspiration material are strongly associated with papillary carcinoma at resection. Am J Clin Pathol. 2002 Aug; 118(2):208-10. PMID: 12162679.
      View in: PubMed
    208. D'Amico AV, Saegaert T, Chen MH, Renshaw AA, George D, Oh W, Kantoff PW. Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer. Cancer. 2002 Jul 15; 95(2):275-80. PMID: 12124826.
      View in: PubMed
    209. D'Amico AV, Whittington R, Malkowicz SB, Cote K, Loffredo M, Schultz D, Chen MH, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer. 2002 Jul 15; 95(2):281-6. PMID: 12124827.
      View in: PubMed
    210. D'Amico AV, Keshaviah A, Manola J, Cote K, Loffredo M, Iskrzytzky O, Renshaw AA. Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2002 Jul 01; 53(3):581-7. PMID: 12062600.
      View in: PubMed
    211. Renshaw AA. Can mucinous lesions of the breast be reliably diagnosed by core needle biopsy? Am J Clin Pathol. 2002 Jul; 118(1):82-4. PMID: 12109860.
      View in: PubMed
    212. Pitman MB, Cibas ES, Powers CN, Renshaw AA, Frable WJ. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear. Cancer. 2002 Jun 25; 96(3):128-34. PMID: 12115299.
      View in: PubMed
    213. Cross CK, Shultz D, Malkowicz SB, Huang WC, Whittington R, Tomaszewski JE, Renshaw AA, Richie JP, D'Amico AV. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate. J Clin Oncol. 2002 Jun 15; 20(12):2863-8. PMID: 12065563.
      View in: PubMed
    214. Renshaw AA. Déjà vu in pap testing: return of the 5% false-negative fraction and the zero-error rate. Diagn Cytopathol. 2002 Jun; 26(6):343-4. PMID: 12112821.
      View in: PubMed
    215. D'Amico AV, Chen MH, Malkowicz SB, Whittington R, Renshaw AA, Tomaszewski JE, Samofalov Y, Wein A, Richie JP. Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate and a prostatic specific antigen level of 4 ng/ml. Or less. J Urol. 2002 May; 167(5):2025-30; discussion 2030-1. PMID: 11956431.
      View in: PubMed
    216. Renshaw AA, Pinnar NE, Jiroutek MR, Young ML. Quantifying the value of in-house consultation in surgical pathology. Am J Clin Pathol. 2002 May; 117(5):751-4. PMID: 12090424.
      View in: PubMed
    217. Renshaw AA, Cartagena N, Derhagopian RP, Gould EW. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol. 2002 May; 117(5):797-9. PMID: 12090431.
      View in: PubMed
    218. Renshaw A. Assessment of morphometric measurements of prostate carcinoma volume. Cancer. 2002 Apr 15; 94(8):2309-10. PMID: 12001133.
      View in: PubMed
    219. Renshaw A. Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy. Cancer. 2002 Apr 15; 94(8):2310-1; author reply 2311-2. PMID: 12001134.
      View in: PubMed
    220. Renshaw A, McCowen T, Waltke EA, Wattenhofer SP, Tahara RW, Baxter BT. Angioplasty with stenting is effective in treating blue toe syndrome. Vasc Endovascular Surg. 2002 Mar-Apr; 36(2):155-9. PMID: 11951102.
      View in: PubMed
    221. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub TR, Sellers WR. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell. 2002 Mar; 1(2):203-9. PMID: 12086878.
      View in: PubMed
    222. Renshaw AA. Qualification of ASCUS. Am J Clin Pathol. 2002 Feb; 117(2):333-6. PMID: 11863232.
      View in: PubMed
    223. Renshaw AA. Predicting invasion in the excision specimen from breast core needle biopsy specimens with only ductal carcinoma in situ. Arch Pathol Lab Med. 2002 Jan; 126(1):39-41. PMID: 11800645.
      View in: PubMed
    224. Renshaw AA, Gould EW. Why there is the tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2002 Jan; 117(1):19-21. PMID: 11789725.
      View in: PubMed
    225. Renshaw AA, Genest DR, Cibas ES. Should atypical squamous cells of undetermined significance (ASCUS) be subcategorized? Accuracy analysis of Papanicolaou smears using receiver operating characteristic curves and implications for the ASCUS/squamous intraepithelial lesion ratio. Am J Clin Pathol. 2001 Nov; 116(5):692-5. PMID: 11710685.
      View in: PubMed
    226. Renshaw AA. Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. Am J Clin Pathol. 2001 Oct; 116(4):477-82. PMID: 11601131.
      View in: PubMed
    227. Renshaw AA. Atlas of Bone Marrow and Blood Pathology. Adv Anat Pathol. 2001 Sep; 8(5):303. PMID: 11707621.
      View in: PubMed
    228. D'Amico AV, Whittington R, Malkowicz SB, Renshaw AA, Tomaszewski JE, Bentley C, Schultz D, Rocha S, Wein A, Richie JP. Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screening. Urology. 2001 Sep; 58(3):406-10. PMID: 11549489.
      View in: PubMed
    229. Renshaw AA. Estimating the percentage of Papanicolaou smears that can be reproducibly identified: modeling Papanicolaou smear interpretation based on multiple blinded rescreenings. Cancer. 2001 Aug 25; 93(4):241-5. PMID: 11507696.
      View in: PubMed
    230. Renshaw AA. Adequate histologic sampling of breast core needle biopsies. Arch Pathol Lab Med. 2001 Aug; 125(8):1055-7. PMID: 11473457.
      View in: PubMed
    231. Renshaw AA. Improved reporting methods for atypia and atypical ductal hyperplasia in breast core needle biopsy specimens. Potential for interlaboratory comparisons. Am J Clin Pathol. 2001 Jul; 116(1):87-91. PMID: 11447757.
      View in: PubMed
    232. Renshaw AA, Cartagena N, Schenkman RH, Derhagopian RP, Gould EW. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies. Am J Clin Pathol. 2001 Jul; 116(1):92-6. PMID: 11447758.
      View in: PubMed
    233. Renshaw AA, Rabaza JR, Gonzalez AM, Verdeja JC. Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity. Obes Surg. 2001 Jun; 11(3):281-3. PMID: 11433901.
      View in: PubMed
    234. Renshaw AA. Follicular lesions of the thyroid. Am J Clin Pathol. 2001 May; 115(5):782-5. PMID: 11345845.
      View in: PubMed
    235. Datta MW, Macri E, Signoretti S, Renshaw AA, Loda M. Transition from in situ to invasive testicular germ cell neoplasia is associated with the loss of p21 and gain of mdm-2 expression. Mod Pathol. 2001 May; 14(5):437-42. PMID: 11353054.
      View in: PubMed
    236. Renshaw AA. An accurate and precise methodology for routine determination of the false-negative rate of Papanicolaou smear screening. Cancer. 2001 Apr 25; 93(2):86-92. PMID: 11309772.
      View in: PubMed
    237. Renshaw AA, Lezon KM, Wilbur DC. The human false-negative rate of rescreening Pap tests. Measured in a two-arm prospective clinical trial. Cancer. 2001 Apr 25; 93(2):106-10. PMID: 11309775.
      View in: PubMed
    238. Lee AK, Schultz D, Renshaw AA, Richie JP, D'Amico AV. Optimizing patient selection for prostate monotherapy. Int J Radiat Oncol Biol Phys. 2001 Mar 01; 49(3):673-7. PMID: 11172948.
      View in: PubMed
    239. Renshaw AA. Measuring and reporting errors in surgical pathology. Lessons from gynecologic cytology. Am J Clin Pathol. 2001 Mar; 115(3):338-41. PMID: 11242788.
      View in: PubMed
    240. D'Amico AV, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA. The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2001 Mar 01; 49(3):679-84. PMID: 11172949.
      View in: PubMed
    241. D'Amico AV, Wu Y, Chen MH, Nash M, Renshaw AA, Richie JP. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. J Urol. 2001 Jan; 165(1):126-9. PMID: 11125380.
      View in: PubMed
    242. Faquin WC, Brown FM, Krane JF, Renshaw AA, Cibas ES. Extensively keratinized squamous intraepithelial lesions of the cervix are difficult to grade. Am J Clin Pathol. 2001 Jan; 115(1):80-4. PMID: 11190810.
      View in: PubMed
    243. Renshaw A, Childs C. The significance of peripheral skin temperature measurement during the acute phase of burn injury: an illustrative case report. Burns. 2000 Dec; 26(8):750-3. PMID: 11024610.
      View in: PubMed
    244. Rubin BP, Pins MR, Nielsen GP, Rosen S, Hsi BL, Fletcher JA, Renshaw AA. Isochromosome 7q in adult Wilms' tumors: diagnostic and pathogenetic implications. Am J Surg Pathol. 2000 Dec; 24(12):1663-9. PMID: 11117788.
      View in: PubMed
    245. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancer. Prostate Cancer Prostatic Dis. 2000 Dec; 3(4):259-264. PMID: 12497074.
      View in: PubMed
    246. Renshaw AA. Experts in Wonderland: in search of the right test and the scientific method. Diagn Cytopathol. 2000 Nov; 23(5):297-8. PMID: 11074620.
      View in: PubMed
    247. D'Amico AV, Wu Y, Chen MH, Nash M, Renshaw AA, Richie JP. Pathologic findings and prostate specific antigen outcome after radical prostatectomy for patients diagnosed on the basis of a single microscopic focus of prostate carcinoma with a gleason score
      View in: PubMed
    248. D'Amico AV, Whittington R, Malkowicz SB, Wu YH, Chen MH, Hurwitz M, Kantoff PW, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials. J Clin Oncol. 2000 Sep 15; 18(18):3240-6. PMID: 10986056.
      View in: PubMed
    249. D'Amico AV, Schultz D, Loffredo M, Dugal R, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA, Kantoff PW. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. JAMA. 2000 Sep 13; 284(10):1280-3. PMID: 10979115.
      View in: PubMed
    250. Renshaw AA, Granter SR. Metastatic, sarcomatoid, and PSA- and PAP-negative prostatic carcinoma: diagnosis by fine-needle aspiration. Diagn Cytopathol. 2000 Sep; 23(3):199-201. PMID: 10945910.
      View in: PubMed
    251. Renshaw AA. Subclassifying atypical urinary cytology specimens. Cancer. 2000 Aug 25; 90(4):222-9. PMID: 10966562.
      View in: PubMed
    252. Datta MW, Renshaw AA, Dutta A, Hoffman MA, Loughlin KR. Evaluation of cyclin expression in testicular germ cell tumors: cyclin E correlates with tumor type, advanced clinical stage, and pulmonary metastasis. Mod Pathol. 2000 Jun; 13(6):667-72. PMID: 10874672.
      View in: PubMed
    253. Renshaw AA. Pediatric renal cell carcinomas: where do they fit in the new histologic classification of renal cell carcinoma? Adv Anat Pathol. 2000 May; 7(3):135-40. PMID: 10809218.
      View in: PubMed
    254. Renshaw A. Intratesticular leiomyosarcoma in a young man after high dose doping with oral-turinabol. A case report. Cancer. 2000 May 01; 88(9):2195-7. PMID: 10813736.
      View in: PubMed
    255. Renshaw AA, Freyer DR, Hammers YA. Metastatic metanephric adenoma in a child. Am J Surg Pathol. 2000 Apr; 24(4):570-4. PMID: 10757405.
      View in: PubMed
    256. Renshaw AA. Compassionate conservatism in urinary cytology. Diagn Cytopathol. 2000 Mar; 22(3):137-8. PMID: 10679991.
      View in: PubMed
    257. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Fondurulia J, Chen MH, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol. 2000 Mar; 18(6):1164-72. PMID: 10715284.
      View in: PubMed
    258. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol. 2000 Feb; 24(2):203-10. PMID: 10680888.
      View in: PubMed
    259. Oh WK, Manola J, Renshaw AA, Brodkin D, Loughlin KR, Richie JP, Shapiro CL, Kantoff PW. Smoking and alcohol use may be risk factors for poorer outcome in patients with clear cell renal carcinoma. Urology. 2000 Jan; 55(1):31-5. PMID: 10654890.
      View in: PubMed
    260. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer. Mol Urol. 2000; 4(3):171-5;discussion 177. PMID: 11062371.
      View in: PubMed
    261. Renshaw AA. A practical problem with calculating the false-negative rate of Papanicolaou smear interpretation by rescreening negative cases alone. Cancer. 1999 Dec 25; 87(6):351-3. PMID: 10603188.
      View in: PubMed
    262. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Renshaw AA, Tomaszewski JE, Richie JP, Wein A. Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage. Int J Radiat Oncol Biol Phys. 1999 Dec 01; 45(5):1227-33. PMID: 10613317.
      View in: PubMed
    263. D'Amico AV, Renshaw AA, Arsenault L, Schultz D, Richie JP. Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy. Int J Radiat Oncol Biol Phys. 1999 Nov 01; 45(4):841-6. PMID: 10571187.
      View in: PubMed
    264. D'Amico AV, Renshaw AA, Schultz D, Rocha S, Richie JP. The impact of the biopsy Gleason score on PSA outcome for prostate cancer patients with PSA < or = 10 ng/ml and T1c,2a: implications for patient selection for prostate-only therapy. Int J Radiat Oncol Biol Phys. 1999 Nov 01; 45(4):847-51. PMID: 10571188.
      View in: PubMed
    265. Vargas SO, Jiroutek M, D'Amico AV, Renshaw AA. Distribution of carcinoma in radical prostatectomy specimens in the era of serum prostate-specific antigen testing. Implications for delivery of localized therapy. Am J Clin Pathol. 1999 Sep; 112(3):373-6. PMID: 10478143.
      View in: PubMed
    266. Renshaw AA, Granter SR, Fletcher JA, Kozakewich HP, Corless CL, Perez-Atayde AR. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. Am J Surg Pathol. 1999 Jul; 23(7):795-802. PMID: 10403302.
      View in: PubMed
    267. Granter SR, Renshaw AA. Cytologic analysis of renal angiomyolipoma: a comparison of radiologically classic and challenging cases. Cancer. 1999 Jun 25; 87(3):135-40. PMID: 10385444.
      View in: PubMed
    268. Renshaw AA, Richie JP, Loughlin KR, Jiroutek M, Chung A, D'Amico AV. Maximum diameter of prostatic carcinoma is a simple, inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens. Validation in a cohort of 434 patients. Am J Clin Pathol. 1999 May; 111(5):641-4. PMID: 10230354.
      View in: PubMed
    269. Rubin BP, Fletcher JA, Renshaw AA. Clear cell sarcoma of soft parts: report of a case primary in the kidney with cytogenetic confirmation. Am J Surg Pathol. 1999 May; 23(5):589-94. PMID: 10328092.
      View in: PubMed
    270. Renshaw AA, Bellerose B, DiNisco SA, Minter LJ, Lee KR. False negative rate of cervical cytologic smear screening as determined by rapid rescreening. Acta Cytol. 1999 May-Jun; 43(3):344-50. PMID: 10349360.
      View in: PubMed
    271. Fielding JR, Visweswaran A, Silverman SG, Granter SR, Renshaw AA. CT and ultrasound features of metanephric adenoma in adults with pathologic correlation. J Comput Assist Tomogr. 1999 May-Jun; 23(3):441-4. PMID: 10348452.
      View in: PubMed
    272. Pins MR, Jones EC, Martul EV, Kamat BR, Umlas J, Renshaw AA. Metanephric adenoma-like tumors of the kidney: report of 3 malignancies with emphasis on discriminating features. Arch Pathol Lab Med. 1999 May; 123(5):415-20. PMID: 10235500.
      View in: PubMed
    273. Dry SM, Renshaw AA. Extratesticular extension of germ cell tumors preferentially occurs at the hilum. Am J Clin Pathol. 1999 Apr; 111(4):534-8. PMID: 10191775.
      View in: PubMed
    274. Renshaw AA, Richie JP. Subtypes of renal cell carcinoma. Different onset and sites of metastatic disease. Am J Clin Pathol. 1999 Apr; 111(4):539-43. PMID: 10191776.
      View in: PubMed
    275. Renshaw AA, Cronin JA, Minter LJ, Nappi D, Whitman T, Jiroutek M, Cibas ES. Performance characteristics of rapid (30-second) prescreening. Implications for calculating the false-negative rate and comparison with other quality assurance techniques. Am J Clin Pathol. 1999 Apr; 111(4):517-22. PMID: 10191772.
      View in: PubMed
    276. Hoffman MA, Renshaw AA, Loughlin KR. Squamous cell carcinoma of the penis and microscopic pathologic margins: how much margin is needed for local cure? Cancer. 1999 Apr 01; 85(7):1565-8. PMID: 10193947.
      View in: PubMed
    277. Vargas SO, Jiroutek M, Welch WR, Nucci MR, D'Amico AV, Renshaw AA. Perineural invasion in prostate needle biopsy specimens. Correlation with extraprostatic extension at resection. Am J Clin Pathol. 1999 Feb; 111(2):223-8. PMID: 9930144.
      View in: PubMed
    278. D'Amico AV, Davis A, Vargas SO, Renshaw AA, Jiroutek M, Richie JP. Defining the implant treatment volume for patients with low risk prostate cancer: does the anterior base need to be treated? Int J Radiat Oncol Biol Phys. 1999 Feb 01; 43(3):587-90. PMID: 10078642.
      View in: PubMed
    279. Granter SR, Renshaw AA, Cibas ES. Nontyrosine crystalloids in fine-needle aspiration specimens of the parotid gland: a report of two cases and review of the literature. Diagn Cytopathol. 1999 Jan; 20(1):44-6. PMID: 9884827.
      View in: PubMed
    280. Loughlin KR, Renshaw AA, Kumar S. Expectant management of stage A-1 (T1a) prostate cancer utilizing serum PSA levels: a preliminary report. J Surg Oncol. 1999 Jan; 70(1):49-53. PMID: 9989421.
      View in: PubMed
    281. Renshaw AA, Friedman MM, Rahemtulla A, Granter SR, Dean BR, Cronin JA, Jiroutek M, Cibas ES. Accuracy and reproducibility of estimating the adequacy of the squamous component of cervicovaginal smears. Am J Clin Pathol. 1999 Jan; 111(1):38-42. PMID: 9894452.
      View in: PubMed
    282. Fielding JR, Aliabadi N, Renshaw AA, Silverman SG. Staging of 119 patients with renal cell carcinoma: the yield and cost-effectiveness of pelvic CT. AJR Am J Roentgenol. 1999 Jan; 172(1):23-5. PMID: 9888732.
      View in: PubMed
    283. D'Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Coleman CN. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol. 1999 Jan; 17(1):168-72. PMID: 10458230.
      View in: PubMed
    284. Renshaw AA, Granter SR. A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors. Mod Pathol. 1998 Dec; 11(12):1160-4. PMID: 9872645.
      View in: PubMed
    285. D'Amico AV, Desjardin A, Chen MH, Paik S, Schultz D, Renshaw AA, Loughlin KR, Richie JP. Analyzing outcome-based staging for clinically localized adenocarcinoma of the prostate. Cancer. 1998 Nov 15; 83(10):2172-80. PMID: 9827722.
      View in: PubMed
    286. Granter SR, Renshaw AA, Kozakewich HP, Fletcher JA. The pericentromeric inversion, inv (6)(p25q13), is a novel diagnostic marker in chondromyxoid fibroma. Mod Pathol. 1998 Nov; 11(11):1071-4. PMID: 9831204.
      View in: PubMed
    287. Renshaw AA. Testicular calcifications: incidence, histology and proposed pathological criteria for testicular microlithiasis. J Urol. 1998 Nov; 160(5):1625-8. PMID: 9783919.
      View in: PubMed
    288. Renshaw AA, Madge R, Jiroutek M, Granter SR. Bile duct brushing cytology: statistical analysis of proposed diagnostic criteria. Am J Clin Pathol. 1998 Nov; 110(5):635-40. PMID: 9802349.
      View in: PubMed
    289. Granter SR, Perez-Atayde AR, Renshaw AA. Cytologic analysis of papillary renal cell carcinoma. Cancer. 1998 Oct 25; 84(5):303-8. PMID: 9801205.
      View in: PubMed
    290. Renshaw AA, Loughlin KR, Dutta A. Cyclin A and MIB1 (Ki67) as markers of proliferative activity in primary renal neoplasms. Mod Pathol. 1998 Oct; 11(10):963-6. PMID: 9796723.
      View in: PubMed
    291. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998 Sep 16; 280(11):969-74. PMID: 9749478.
      View in: PubMed
    292. Renshaw AA, Madge R, Sugarbaker DJ, Swanson S. Malignant pleural effusions after resection of pulmonary adenocarcinoma. Acta Cytol. 1998 Sep-Oct; 42(5):1111-5. PMID: 9755666.
      View in: PubMed
    293. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Loughlin KR, Richie JP, Wein A. Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy. J Clin Oncol. 1998 Sep; 16(9):3094-100. PMID: 9738580.
      View in: PubMed
    294. Renshaw AA, Richie JP, Loughlin KR, Jiroutek M, Chung A, D'Amico AV. The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens. Cancer. 1998 Aug 15; 83(4):748-52. PMID: 9708940.
      View in: PubMed
    295. Renshaw AA. Correlation of gross morphologic features with histologic features in radical prostatectomy specimens. Am J Clin Pathol. 1998 Jul; 110(1):38-42. PMID: 9661921.
      View in: PubMed
    296. Renshaw AA, Comiter CV, Nappi D, Granter SR. Effusion cytology of renal cell carcinoma. Cancer. 1998 Jun 25; 84(3):148-52. PMID: 9678728.
      View in: PubMed
    297. Renshaw AA, Santis WF, Richie JP. Clinicopathological characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies. J Urol. 1998 Jun; 159(6):2018-21; discussion 2022. PMID: 9598510.
      View in: PubMed
    298. D'Amico AV, Desjardin A, Chung A, Chen MH, Schultz D, Whittington R, Malkowicz SB, Wein A, Tomaszewski JE, Renshaw AA, Loughlin K, Richie JP. Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy. Cancer. 1998 May 15; 82(10):1887-96. PMID: 9587121.
      View in: PubMed
    299. Comiter CV, Kibel AS, Richie JP, Nucci MR, Renshaw AA. Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases. J Urol. 1998 Mar; 159(3):859-63. PMID: 9474169.
      View in: PubMed
    300. Krane JF, Renshaw AA. Relative value and cost-effectiveness of culture and special stains in fine needle aspirates of the lung. Acta Cytol. 1998 Mar-Apr; 42(2):305-11. PMID: 9568128.
      View in: PubMed
    301. Dry SM, Renshaw AA. Extensive calcium oxalate crystal deposition in papillary renal cell carcinoma: report of two cases. Arch Pathol Lab Med. 1998 Mar; 122(3):260-1. PMID: 9823865.
      View in: PubMed
    302. Freeman MR, Paul S, Kaefer M, Ishikawa M, Adam RM, Renshaw AA, Elenius K, Klagsbrun M. Heparin-binding EGF-like growth factor in the human prostate: synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen. J Cell Biochem. 1998 Mar 01; 68(3):328-38. PMID: 9518259.
      View in: PubMed
    303. Goldstein ML, Whitman T, Renshaw AA. Significance of cell groups in voided urine. Acta Cytol. 1998 Mar-Apr; 42(2):290-4. PMID: 9568125.
      View in: PubMed
    304. Renshaw AA, Nappi D, Sugarbaker DJ, Swanson S. Effusion cytology of esophageal carcinoma. Cancer. 1997 Dec 25; 81(6):365-72. PMID: 9438462.
      View in: PubMed
    305. Granter SR, Fletcher JA, Renshaw AA. Cytologic and cytogenetic analysis of metanephric adenoma of the kidney: a report of two cases. Am J Clin Pathol. 1997 Nov; 108(5):544-9. PMID: 9353093.
      View in: PubMed
    306. Steele GS, Fielding JR, Renshaw A, Loughlin KR. Transitional cell carcinoma of the fossa navicularis. Urology. 1997 Nov; 50(5):792-5. PMID: 9372897.
      View in: PubMed
    307. Renshaw AA, DiNisco SA, Minter LJ, Cibas ES. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process. Cancer. 1997 Oct 25; 81(5):272-6. PMID: 9349513.
      View in: PubMed
    308. Renshaw AA. Analysis of error in calculating the false-negative rate in the interpretation of cervicovaginal smears: the need to review abnormal cases. Cancer. 1997 Oct 25; 81(5):264-71. PMID: 9349512.
      View in: PubMed
    309. Renshaw AA, Zhang H, Corless CL, Fletcher JA, Pins MR. Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features. Am J Surg Pathol. 1997 Oct; 21(10):1203-9. PMID: 9331293.
      View in: PubMed
    310. Renshaw AA, Dean BR, Cibas ES. Receiver operating characteristic curves for analysis of the results of cervicovaginal smears. A useful quality improvement tool. Arch Pathol Lab Med. 1997 Sep; 121(9):968-75. PMID: 9302930.
      View in: PubMed
    311. Renshaw AA, Granter SR. Appropriate follow-up interval for biopsy confirmation of squamous intraepithelial lesions diagnosed by cervical smear cytology. Am J Clin Pathol. 1997 Sep; 108(3):275-9. PMID: 9291454.
      View in: PubMed
    312. Renshaw AA, Lee KR, Granter SR. Use of statistical analysis of cytologic interpretation to determine the causes of interobserver disagreement and in quality improvement. Cancer. 1997 Aug 25; 81(4):212-9. PMID: 9292736.
      View in: PubMed
    313. Renshaw AA, Gordon M, Corless CL. Immunohistochemistry of unclassified sex cord-stromal tumors of the testis with a predominance of spindle cells. Mod Pathol. 1997 Jul; 10(7):693-700. PMID: 9237180.
      View in: PubMed
    314. Renshaw AA, Madge R, Granter SR. Intracytoplasmic eosinophilic inclusions (Melamed-Wolinska bodies). Association with metastatic transitional cell carcinoma in pleural fluid. Acta Cytol. 1997 Jul-Aug; 41(4):995-8. PMID: 9250290.
      View in: PubMed
    315. Renshaw AA, Lee KR, Madge R, Granter SR. Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma. Acta Cytol. 1997 Jul-Aug; 41(4):987-94. PMID: 9250289.
      View in: PubMed
    316. Renshaw AA, Madge R. Cercariform cells for helping distinguish transitional cell carcinoma from non-small cell lung carcinoma in fine needle aspirates. Acta Cytol. 1997 Jul-Aug; 41(4):999-1007. PMID: 9250291.
      View in: PubMed
    317. Renshaw AA, Chang H, D'Amico AV. Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice. Am J Clin Pathol. 1997 Jun; 107(6):704-8. PMID: 9169669.
      View in: PubMed
    318. Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol. 1997 Jun; 21(6):621-35. PMID: 9199639.
      View in: PubMed
    319. Renshaw AA, Doolittle MH. Value of Gram's stain of cell block material from peritoneal fluid in bacterial peritonitis. Acta Cytol. 1997 May-Jun; 41(3):755-8. PMID: 9167697.
      View in: PubMed
    320. Renshaw AA, Fletcher JA. Trisomy 3 in renal cell carcinoma. Mod Pathol. 1997 May; 10(5):481-4. PMID: 9160314.
      View in: PubMed
    321. Granter SR, Renshaw AA. Fine-needle aspiration of chromophobe renal cell carcinoma. Analysis of six cases. Cancer. 1997 Apr 25; 81(2):122-8. PMID: 9126140.
      View in: PubMed
    322. Renshaw AA, Granter SR, Cibas ES. Fine-needle aspiration of the adult kidney. Cancer. 1997 Apr 25; 81(2):71-88. PMID: 9126135.
      View in: PubMed
    323. Freeman MR, Yoo JJ, Raab G, Soker S, Adam RM, Schneck FX, Renshaw AA, Klagsbrun M, Atala A. Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J Clin Invest. 1997 Mar 01; 99(5):1028-36. PMID: 9062361; PMCID: PMC507911.
      View in: PubMed, PubMed Central
    324. D'Amico AV, Chang H, Holupka E, Renshaw A, Desjarden A, Chen M, Loughlin KR, Richie JP. Calculated prostate cancer volume: the optimal predictor of actual cancer volume and pathologic stage. Urology. 1997 Mar; 49(3):385-91. PMID: 9123703.
      View in: PubMed
    325. Renshaw AA, Maurici D, Fletcher JA. Cytologic and fluorescence in situ hybridization (FISH) examination of metanephric adenoma. Diagn Cytopathol. 1997 Feb; 16(2):107-11. PMID: 9067099.
      View in: PubMed
    326. Renshaw AA, Nappi D, Swanson S, Sugarbaker DJ. Effusion cytology after extrapleural pneumonectomy for treatment of malignant mesothelioma. Am J Clin Pathol. 1997 Feb; 107(2):206-10. PMID: 9024069.
      View in: PubMed
    327. Renshaw AA. Adequate tissue sampling of prostate core needle biopsies. Am J Clin Pathol. 1997 Jan; 107(1):26-9. PMID: 8980363.
      View in: PubMed
    328. Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest. 1997 Jan; 111(1):106-9. PMID: 8996002.
      View in: PubMed
    329. Granter SR, Renshaw AA, Fletcher CD, Bhan AK, Rosenberg AE. CD99 reactivity in mesenchymal chondrosarcoma. Hum Pathol. 1996 Dec; 27(12):1273-6. PMID: 8958297.
      View in: PubMed
    330. Renshaw AA, Perez-Atayde AR, Fletcher JA, Granter SR. Cytology of typical and atypical Ewing's sarcoma/PNET. Am J Clin Pathol. 1996 Nov; 106(5):620-4. PMID: 8929472.
      View in: PubMed
    331. Huang SF, Xiao S, Renshaw AA, Loughlin KR, Hudson TJ, Fletcher JA. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer. Am J Pathol. 1996 Nov; 149(5):1565-73. PMID: 8909246; PMCID: PMC1865289.
      View in: PubMed, PubMed Central
    332. Renshaw AA, Henske EP, Loughlin KR, Shapiro C, Weinberg DS. Aggressive variants of chromophobe renal cell carcinoma. Cancer. 1996 Oct 15; 78(8):1756-61. PMID: 8859189.
      View in: PubMed
    333. Olumi AF, Garnick MB, Renshaw AA, Benson CA, Richie JP. Leydig cell hyperplasia mimicking testicular neoplasm. Urology. 1996 Oct; 48(4):647-9. PMID: 8886077.
      View in: PubMed
    334. Jones D, Renshaw AA. Recurrent crystal-storing histiocytosis of the lung in a patient without a clonal lymphoproliferative disorder. Arch Pathol Lab Med. 1996 Oct; 120(10):978-80. PMID: 12046613.
      View in: PubMed
    335. Renshaw AA, Granter SR. Fine needle aspiration of chromophobe renal cell carcinoma. Acta Cytol. 1996 Sep-Oct; 40(5):867-72. PMID: 8842158.
      View in: PubMed
    336. Jones D, Weinberg DS, Pinkus GS, Renshaw AA. Cytologic diagnosis of primary serous lymphoma. Am J Clin Pathol. 1996 Sep; 106(3):359-64. PMID: 8816594.
      View in: PubMed
    337. Renshaw AA. Prostatic carcinoma. Diagnostic pathology and prognosis. Magn Reson Imaging Clin N Am. 1996 Aug; 4(3):439-48. PMID: 8873012.
      View in: PubMed
    338. Renshaw AA, Nappi D, Cibas ES. Cytology of metastatic adenocarcinoma of the prostate in pleural effusions. Diagn Cytopathol. 1996 Aug; 15(2):103-7. PMID: 8872430.
      View in: PubMed
    339. Renshaw AA, Nappi D, Weinberg DS. Cytology of grade 1 papillary transitional cell carcinoma. A comparison of cytologic, architectural and morphometric criteria in cystoscopically obtained urine. Acta Cytol. 1996 Jul-Aug; 40(4):676-82. PMID: 8693885.
      View in: PubMed
    340. Comiter CV, Renshaw AA, Benson CB, Loughlin KR. Burned-out primary testicular cancer: sonographic and pathological characteristics. J Urol. 1996 Jul; 156(1):85-8. PMID: 8648846.
      View in: PubMed
    341. D'Amico AV, Whittington R, Malkowicz SB, Loughlin K, Schultz D, Schnall M, Tempany CM, Tomaszewski JE, Renshaw A, Wein A. An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: implications on the use of adjuvant therapy. Urology. 1996 Apr; 47(4):538-47. PMID: 8638365.
      View in: PubMed
    342. Granter SR, Doolittle MH, Renshaw AA. Predominance of neutrophils in the cerebrospinal fluid of AIDS patients with cytomegalovirus radiculopathy. Am J Clin Pathol. 1996 Mar; 105(3):364-6. PMID: 8602619.
      View in: PubMed
    343. Fletcher JA, Renshaw AA. Isochromosome 7q in adult Wilms' tumor. Cancer Genet Cytogenet. 1996 Feb; 86(2):168-9. PMID: 8603348.
      View in: PubMed
    344. Renshaw AA, Stelling JM, Doolittle MH. The lack of value of repeated Clostridium difficile cytotoxicity assays. Arch Pathol Lab Med. 1996 Jan; 120(1):49-52. PMID: 8554444.
      View in: PubMed
    345. Xiao S, Renshaw A, Cibas ES, Hudson TJ, Fletcher JA. Novel fluorescence in situ hybridization approaches in solid tumors. Characterization of frozen specimens, touch preparations, and cytological preparations. Am J Pathol. 1995 Oct; 147(4):896-904. PMID: 7573365; PMCID: PMC1871023.
      View in: PubMed, PubMed Central
    346. Renshaw AA, Corless CL. Papillary renal cell carcinoma. Histology and immunohistochemistry. Am J Surg Pathol. 1995 Jul; 19(7):842-9. PMID: 7540804.
      View in: PubMed
    347. Renshaw AA. The relative sensitivity of special stains and culture in open lung biopsies. Am J Clin Pathol. 1994 Dec; 102(6):736-40. PMID: 7528466.
      View in: PubMed
    348. Renshaw AA, Rosai J. Benign atypical vascular lesions of the lip. A study of 12 cases. Am J Surg Pathol. 1993 Jun; 17(6):557-65. PMID: 8333555.
      View in: PubMed
    349. Gerhart TN, Roux RD, Hanff PA, Horowitz GL, Renshaw AA, Hayes WC. Antibiotic-loaded biodegradable bone cement for prophylaxis and treatment of experimental osteomyelitis in rats. J Orthop Res. 1993 Mar; 11(2):250-5. PMID: 8483037.
      View in: PubMed
    350. Gerhart TN, Renshaw AA, Miller RL, Noecker RJ, Hayes WC. In vivo histologic and biomechanical characterization of a biodegradable particulate composite bone cement. J Biomed Mater Res. 1989 Jan; 23(1):1-16. PMID: 2708400.
      View in: PubMed
    Renshaw's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (594) concept(s)
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department
    Physical Neighbors Expand Description
    _